iBio shares are trading higher after the company reported the purchase of a FastPharming manufacturing facility for $28.75 million. by | Nov 4, 2021 | Uncategorized | 0 comments Meritas Media Team Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Recent Comments